A randomised controlled trial to evaluate the effectiveness of zoledronate therapy in osteonecrosis of the hip. [ 2010 - 2015 ]

Research Grant

Researchers: Prof Lyn March (Principal investigator) ,  Prof Philip Sambrook (Principal investigator) ,  Prof David Little ,  Prof Rachelle Buchbinder

Brief description Osteonecrosis of the hip is an important cause of musculoskeletal disability and finding therapeuticsolutions has proven to be challenging. A wide range of surgical treatments with variable success rates ahve been proposed for the treatment. Non-surgical treatment options are limited and usually result in a poor prognosis. This novel clinical trial research will study the protective value of a bisphosphonate in patients with osteonecrosis of the hip and evaluate the cost-effectiveness.

Funding Amount $AUD 535,441.68

Funding Scheme Project Grants

Notes Standard Project Grant